Infina Connect Document For Safety

A+KIDS Resources

Training and Resources

The Treatment of Maladaptive Aggression in Youth (T-MAY). A web-based curriculum for prescribers of antipsychotic medication. (PDF) Centers for Disease Control BMI Calculator for Children/Adolescents Texas Psychotropic Medication Utilization Parameters for Foster Children REACH Institute T-MAY Training Modules

Movement Disorder Assessment Information

Abnormal Involuntary Movement Scale (AIMS) - Overview (PDF) Assessment for Involuntary Movement Scale (AIMS) Form (PDF) AIMS Form Instructions (PDF)

Evidence Based Medicine

Outpatient use of Atypical Antipsychotic Agents in the Pediatric Population Years 2004-2008 (PDF) Multi-State Study on Psychotropic Medication Oversight in Foster Care (PDF) Tapering of Antipsychotic Medications (PDF) Double blind comparison of first and second gen apx in early-onset scz and sad findings from the treatment of early-onset scz spectrum disorders (TEOSS) study (PDF) Antipsychotic use in children and adolescents minimizing adverse effects to maximize outcomes (PDF) Tardive dyskinesia and new antipsychotics (PDF) Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients (PDF) Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents (PDF) Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents (PDF) Addressing adverse effects of antipsychotic treatment in young patients with schizophrenia (PDF) TEOSS Study (PDF) Consensus development conference on antipsychotic drugs and obesity and diabetes (PDF)